Brief: Lucent Oil carries out reverse acquisition of QuiaPEG Pharmaceuticals
30/11/2016 15:54
Nov 30 (Reuters) - Lucent Oil AB LUCE.ST :
* Says signed an agreement to acquire 79.4% of all shares in QuiaPEG Pharmaceuticals AB
(QuiaPEG) with the intent to acquire 100% stake in QuiaPEG
* The transaction is carried out in two steps
* Lucent will in 2016 participate in a rights issue of new shares in QuiaPEG with 2.5
million Swedish crowns ($271,070.29) of a total of 5.0 million crowns; Lucent's stake in step 1
amounts to 7.5% of capital and votes in QuiaPEG
* In March 2017, the intention is to acquire the remaining 92.5% stake in QuiaPEG through
the issue of up to 18,234,232 new shares in Lucent for a total value of no more than 32.5
million crowns
Source text: http://bit.ly/2gxFzrV
Further company coverage: LUCE.ST
($1 = 9.2227 Swedish crowns)
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))